π Calcium channel blockers (CCBs) are used in the treatment of many cardiovascular conditions including hypertension and angina. They are divided into subclasses, non-dihydropyridines, and dihydropyridines and differ by their pharmacokinetic properties, clinical uses, response, and selectivity. β
β
π The name of this class, calcium channel blockers, hints at its mechanism of action β inhibits the entry of calcium into cells of the cardiac and peripheral vascular smooth muscles. β
β
ποΈ Calcium entry into L-type channels of cardiac and peripheral vascular cells is needed for them to contract or constrict more strongly. β
β
ποΈ By blocking calcium entry, calcium channel blockers cause:β
ππ» peripheral vascular smooth muscle relaxation (decreases blood pressure)β
ππ» decreased myocardial contractility (decrease myocardial demand making them effective in angina)β
ππ» decrease heart rate and conduction velocity (useful in arrhythmias). β
Pharmacy Education - Redesigning how we learn medicine.